A survey has found that the US leads in biotech quality and commercial reach, but china is closing in. However, the extent of the US lead and the pace of china's progress are unclear, with some reports suggesting the US is at risk of losing its leadership in biomedical innovation. The issue of biotech competition between the US and china is being discussed in various contexts, including policy and industry developments.